Recent Finacing
Recent Raise
Argos Therapeutics is a Durham-based biopharmaceutical company developing fully personalized dendritic cell immunotherapies via its Arcelis platform, advancing AGS-003 for metastatic renal cell carcinoma and AGS-004 for HIV.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
